Kiwi “Note. “This study suggests that early aspirin use may be associated with lower odds of in-hospital mortality among hospitalized patients with moderate COVID-19”
This is also interesting because aspirin interacts with the COX-2 receptor in the endothelium leading to increased production of E Series Resolvins.
What if the cardio protective actions of ASA are the result of increased E Series Resolvins and not (just) anti platelet actions???
A review of the R-it data comparing ASA/EPA efficacy vs EPA alone would be interesting.
Market Data 
Markets 
AI
